High variability in baseline urinary free cortisol values in patients with Cushing's disease.
about
Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how?Cushing's syndrome: epidemiology and developments in disease management.Cushing's syndrome: update on signs, symptoms and biochemical screening.Variability in laboratory parameters used for management of Cushing's syndrome.Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.Cushing's syndrome: from physiological principles to diagnosis and clinical care.Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.Pituitary-directed medical therapy in Cushing's disease.Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing's disease in Brazil.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSH.How useful is urinary-free cortisol in the clinic?Long-term cortisol measures predict Alzheimer disease risk.Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.Pituitary-Directed Therapies for Cushing's Disease.
P2860
Q35055020-9677DEA7-4EF2-46BE-B53E-484A6670ED3EQ35531889-FF405AAD-9D5C-4D61-AA45-6123C7951FB1Q36005863-AD3DA07C-A66E-4B8A-8897-AE3849D58272Q36327131-AC921D6C-13C3-4E26-A5DD-EA5F71B9D2E4Q37373227-A2CEC3E9-F73C-4EC3-8EC0-17D4D853C8DDQ38284048-95179417-1317-4B39-9DD9-78E3734DC920Q38307934-785458DD-32C6-4B1B-A4C7-DB58D19604FCQ38334659-93BA01AE-F256-45F5-B8A7-58BDF632EDA3Q38445603-CC36E5E5-3E9E-4692-9C21-E9F768FCCED0Q40313813-525779DF-BDEC-4E6C-9B48-C88A9034B5EAQ40632126-F0867B6A-F756-4D4A-854C-38EA169F4586Q40795123-96E6F5C4-1ABD-4011-B6C4-A10CC597B2DEQ47859835-C6F89540-E109-4454-AB16-3C536E868EDBQ48402527-0C6C4FE0-9536-46A1-8FA0-F196BDA4E6A8Q50078282-093CEA5B-7837-4173-A617-A652A1328710Q50318467-71DFEBD0-2B98-4B44-8134-9D03D2A973E5Q51071222-498BEDCB-D6F3-4520-B3D2-E49AEF7A8A72Q54961209-F17A80AA-5C44-4323-A4CC-02EBBAE06E6F
P2860
High variability in baseline urinary free cortisol values in patients with Cushing's disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
High variability in baseline u ...... tients with Cushing's disease.
@ast
High variability in baseline u ...... tients with Cushing's disease.
@en
High variability in baseline u ...... tients with Cushing's disease.
@nl
type
label
High variability in baseline u ...... tients with Cushing's disease.
@ast
High variability in baseline u ...... tients with Cushing's disease.
@en
High variability in baseline u ...... tients with Cushing's disease.
@nl
prefLabel
High variability in baseline u ...... tients with Cushing's disease.
@ast
High variability in baseline u ...... tients with Cushing's disease.
@en
High variability in baseline u ...... tients with Cushing's disease.
@nl
P2093
P2860
P356
P1476
High variability in baseline u ...... tients with Cushing's disease.
@en
P2093
B M K Biller
J Newell-Price
J W Findling
L R Salgado
M Maldonado
Pasireotide B2305 Study Group
S Petersenn
P2860
P304
P356
10.1111/CEN.12259
P577
2013-07-15T00:00:00Z